Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.

@article{Boutitie1999AmiodaroneIW,
  title={Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.},
  author={Florent Boutitie and Jean Pierre Boissel and Stuart J. Connolly and A. John Camm and John Cairns and Desmond G. Julian and Michael J. Gent and Michiel J. Janse and P. Dorian and Gerald Frangin},
  journal={Circulation},
  year={1999},
  volume={99 17},
  pages={2268-75}
}
BACKGROUND Investigations with in vitro and animal models suggest an interaction between amiodarone and beta-blockers. The objective of this work was to explore if an interaction with beta-blocker treatment plays a role in the decrease of cardiac arrhythmic deaths with amiodarone in patients recovered from an acute myocardial infarction. METHODS AND… CONTINUE READING